Precision Treatment to Promote Smoking Cessation and Survival in Oncology Patients
Recruiting
N/A
Interventional Study
Smoking Cessation
Smoking
Physician's Role
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 89
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 132 (estimated)
- Sponsor
- Washington University School of Medicine · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study evaluates the feasibility and preliminary effects of precision tobacco treatment, compared to usual care, on promoting tobacco treatment in oncology patients and providers in the oncology care setting. The precision treatment intervention includes personalized tobacco treatment recommendations using the patient's clinical, genetic, and biomarker information. This intervention may increa…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Eligibility Criteria for Clinicians:
* Clinician from participating oncology/hematology clinic
* At least 18 years of age
* Can speak and understand English
Inclusion Criteria for Patients:
* Patient at participating clinic
* Age 18-89 years
* Current smoking (average cigarettes per day ≥5)
* Can…
Contacts